Summary
Roche's LightCycler 2.0 real-time PCR for MRSA will need further validation from designed quality control testing by unbiased clinical diagnostic laboratories. Provided the new test procedure for MRSA meets the criteria for accuracy, then, clinical tests could prove useful to evaluate the epidemiology of MRSA in various situations.
Analysis
Real-time PCR offers a economic and adaptable procedure to study large numbers of infections with such agents MRSA in various clinical environments. Foremost, are infections that are hospital acquired or community acquired. Also, since some MRSA infections are believed to be zoonotic the use of this real-time PCR test could prove to be of benefit in veterinary studies.
This author consults with leading institutions through GLG
Analyses are solely the work of the authors and have not been edited or endorsed by GLG.
